Engineered Stem Cell Derived NKT & Gamma Delta T-cell Therapies: Scalable Products with Enhanced Safety for Autoimmune Diseases
Time: 2:00 pm
day: Day One Track A, PM
Details:
• Highlighting strong efficacy and depth of B-cell depletion, comparable to CAR-T cells in preclinical models
• Discussing modifications of NKT and gamma delta T-cells for reduced risk of adverse events such as CRS and ICANS
• Elucidating key market advantages of NKT cells, such as scalable manufacturing and off-the-shelf availability
